FTC Clearance Of Hospira’s Mayne Acquisition Hinges On Generic Divestitures
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm must sell five generic injectable drugs to Barr under FTC consent order to complete $2 billion acquisition of Australian company.
You may also be interested in...
FTC Clears Barr’s Acquisition Of Pliva Based On Divestiture Of Generic Drugs
Barr must divest three generic products – trazodone, triamterene/HCTZ and nimodipine – to Apotex and Banner.
Hospira’s Mayne Event: Acquisition Strengthens Oncology Portfolio
Merger will create the leading generic injectable pharmaceutical company in the world.
Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.